BR9007115A - Novo trombolitico - Google Patents

Novo trombolitico

Info

Publication number
BR9007115A
BR9007115A BR909007115A BR9007115A BR9007115A BR 9007115 A BR9007115 A BR 9007115A BR 909007115 A BR909007115 A BR 909007115A BR 9007115 A BR9007115 A BR 9007115A BR 9007115 A BR9007115 A BR 9007115A
Authority
BR
Brazil
Prior art keywords
trombolitico
new
thrombolitic
novel
treatment
Prior art date
Application number
BR909007115A
Other languages
English (en)
Inventor
Berthold Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernard Jacques Haendler
Gernot Langer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9007115A publication Critical patent/BR9007115A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
BR909007115A 1989-02-13 1990-02-13 Novo trombolitico BR9007115A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum
PCT/EP1990/000242 WO1990009438A1 (en) 1989-02-13 1990-02-13 Novel thrombolytic

Publications (1)

Publication Number Publication Date
BR9007115A true BR9007115A (pt) 1991-11-26

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007115A BR9007115A (pt) 1989-02-13 1990-02-13 Novo trombolitico

Country Status (16)

Country Link
EP (1) EP0383417B1 (pt)
JP (1) JP2904918B2 (pt)
AT (1) ATE132187T1 (pt)
AU (1) AU642404B2 (pt)
BR (1) BR9007115A (pt)
CA (1) CA2046632C (pt)
DE (1) DE69024382T2 (pt)
DK (1) DK0383417T3 (pt)
ES (1) ES2085326T3 (pt)
FI (1) FI103577B (pt)
GR (1) GR3019328T3 (pt)
HU (1) HU217219B (pt)
IE (1) IE73229B1 (pt)
NO (1) NO308708B1 (pt)
UA (1) UA34415C2 (pt)
WO (1) WO1990009438A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
AU2004240748B2 (en) * 2003-05-21 2010-07-15 Ares Trading S.A. Method of chromatographic analysis of a protein solution
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
DE202006015207U1 (de) * 2006-05-19 2007-08-16 Paion Deutschland Gmbh Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie
ATE502960T1 (de) 2006-11-17 2011-04-15 Novartis Ag Lingo bindende moleküle und pharmazeutische verwendung davon
RU2513697C2 (ru) 2007-11-02 2014-04-20 Новартис Аг Улучшенные молекулы, связывающиеся с nogo-а и их фармацевтическое применение
EP2558580A2 (en) 2010-04-16 2013-02-20 H. Lundbeck A/S Method for the manufacture of recombinant dspa alpha1
MX2022004737A (es) 2019-10-24 2023-02-16 Novago Therapeutics Ag Anticuerpos anti-nogo-a novedosos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer

Also Published As

Publication number Publication date
NO308708B1 (no) 2000-10-16
DK0383417T3 (da) 1996-05-13
FI913818A0 (fi) 1991-08-12
GR3019328T3 (en) 1996-06-30
IE900506L (en) 1990-08-13
UA34415C2 (uk) 2001-03-15
EP0383417B1 (en) 1995-12-27
HUT59724A (en) 1992-06-29
IE73229B1 (en) 1997-05-21
AU642404B2 (en) 1993-10-21
CA2046632A1 (en) 1990-08-14
NO913129D0 (no) 1991-08-12
ATE132187T1 (de) 1996-01-15
ES2085326T3 (es) 1996-06-01
EP0383417A1 (en) 1990-08-22
HU902004D0 (en) 1991-11-28
NO913129L (no) 1991-10-11
JP2904918B2 (ja) 1999-06-14
FI103577B1 (fi) 1999-07-30
FI103577B (fi) 1999-07-30
DE69024382T2 (de) 1996-08-14
WO1990009438A1 (en) 1990-08-23
DE69024382D1 (de) 1996-02-08
JPH04504799A (ja) 1992-08-27
HU217219B (hu) 1999-12-28
CA2046632C (en) 1999-05-11
AU5080790A (en) 1990-09-05

Similar Documents

Publication Publication Date Title
FR13C0021I2 (fr) Conjugates d'exendin-4 et leur utilisation medicale
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
EP0787802A3 (pt)
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
DK31088D0 (da) Blodkoaguleringsnedsaettende peptidderivater
BR9007115A (pt) Novo trombolitico
IT1142032B (it) Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche' procedimento per la preparazione
EP0376251A3 (en) An anticoagulant substance obtained from urine
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
IT216694Z2 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DK72088D0 (da) Oximethere af 2,6-dioxabicyclo(3.3.0)octanoner og farmaceutiske praeparater til behandling af hjerte- og blodkredsloebssygdomme
ATE65394T1 (de) Behandlung von knochenschwund.
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C12N 9/72 (2006.01), A61K 38/00 (2006.0